title: Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?
authors.forename: Christoph A
authors.initials: CA
authors.lastname: Fux
authors.forename: Sandra
authors.initials: S
authors.lastname: Baumann
authors.forename: Hansjakob
authors.initials: H
authors.lastname: Furrer
authors.forename: Nicolas J
authors.initials: NJ
authors.lastname: Mueller
mesh_terms: D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines / Q000009:adverse effects*; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014808:Vitamin D Deficiency / Q000139:chemically induced*
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz